A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(33 sites)

United States

Climb Bio Investigative Site #110, Denver, Colorado

Climb Bio Investigative Site #105, Orlando, Florida

Climb Bio Investigative Site #108, Atlanta, Georgia

Climb Bio Investigative Site #106, Indianapolis, Indiana

Climb Bio Investigative Site #101, Clifton Park, New York

Climb Bio Investigative Site #102, Philadelphia, Pennsylvania

Climb Bio Investigative Site #103, El Paso, Texas

Climb Bio Investigative Site #104, Sherman, Texas

Argentina

Climb Bio Investigative Site# 602, Buenos Aires

Climb Bio Investigative Site# 603, Buenos Aires

Climb Bio Investigative Site #601, CABA

Climb Bio Investigative Site #604, CABA

Climb Bio Investigative Site #605, Córdoba

Climb Bio Investigative Site #606, Santa Fe

Brazil

Climb Bio Investigative Site #502, Belo Horizonte

Climb Bio Investigative Site #505, Minas Gerais

Climb Bio Investigative Site #506, Pernambuco

Climb Bio Investigative Site #501, Porto Alegre

Climb Bio Investigative Site #503, São Paulo

Climb Bio Investigative Site #504, São Paulo

Georgia

Climb Bio Investigative Site #903, Tbilisi

Climb Bio Investigative Site #902, Tbilisi

Climb Bio Investigative Site #901, Tbilisi

Taiwan

Climb Bio Investigative Site #204, Taichung

Climb Bio Investigative Site# 202, Taipei

Climb Bio Investigative Site# 201, Taipei

Climb Bio Investigative Site #205, Taipei

Climb Bio Investigative Site# 203, Taipei

Ukraine

Climb Bio Investigative Site #803, Ivano-Frankivsk

Climb Bio Investigative Site# 801, Kyiv

Climb Bio Investigative Site #805, Kyiv

Climb Bio Investigative Site #804, Rivne

Climb Bio Investigative Site #802, Ternopil